Previous close | 6.70 |
Open | 6.70 |
Bid | 5.80 |
Ask | 8.80 |
Strike | 245.00 |
Expiry date | 2024-10-18 |
Day's range | 6.70 - 6.70 |
Contract range | N/A |
Volume | |
Open interest | 44 |
BD's robust product portfolio and a few strategic deals raise optimism about the stock. However, stiff competition and macroeconomic volatility are concerns.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has reached an agreement to resolve the vast majority of its existing hernia litigation.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.